Analyst Activity – Goldman Sachs Group Initiates Coverage On T2 Biosystems (NASDAQ:TTOO) With a Neutral

0

Analyst Ratings For T2 Biosystems (NASDAQ:TTOO)

Today, Goldman Sachs Group initiated coverage on T2 Biosystems (NASDAQ:TTOO) with a Neutral.

Some recent analyst ratings include

  • 1/29/2018-Goldman Sachs Group initiated coverage with a Neutral rating.
  • 1/25/2018-HC Wainwright Reiterated Rating of Buy.
  • 10/30/2017-Canaccord Genuity Reiterated Rating of Buy.
  • 5/8/2017-BTIG Research Upgrade from a “Sell ” rating to a ” Neutral” rating.
  • 3/14/2017-Morgan Stanley was Downgraded by analysts at Morgan Stanley from a “Equal Weight ” rating to a ” Underweight” rating. They now have a $5.00 price target on the stock.
  • 2/5/2017-WBB Securities Reiterated Rating of Buy.

Recent Insider Trading Activity For T2 Biosystems (NASDAQ:TTOO)
T2 Biosystems (NASDAQ:TTOO) has insider ownership of 38.70% and institutional ownership of 59.72%.

  • On 11/16/2017 David B Elsbree, Director, bought 1,500 with an average share price of $4.11 per share and the total transaction amounting to $6,165.00.
  • On 6/6/2017 Darlene M Deptula-Hicks, CFO, bought 4,000 with an average share price of $3.58 per share and the total transaction amounting to $14,320.00.
  • On 6/6/2017 David B Elsbree, Director, bought 10,000 with an average share price of $3.50 per share and the total transaction amounting to $35,000.00.
  • On 6/6/2017 Joanne Spadoro, COO, bought 5,000 with an average share price of $3.50 per share and the total transaction amounting to $17,500.00.
  • On 6/6/2017 Michael Terrence Gibbs, General Counsel, bought 1,000 with an average share price of $3.51 per share and the total transaction amounting to $3,510.00.
  • On 3/15/2017 David B Elsbree, Director, bought 10,000 with an average share price of $5.97 per share and the total transaction amounting to $59,700.00.
  • On 6/30/2016 Rahul Dhanda, SVP, sold 3,589 with an average share price of $8.16 per share and the total transaction amounting to $29,286.24.

Recent Trading Activity for T2 Biosystems (NASDAQ:TTOO)
Shares of T2 Biosystems closed the previous trading session at 4.86 down -0.37 7.07% with shares trading hands.